+351 211 369 829 
Liver Cancer Awareness Month
October marked Liver Cancer Awareness Month, a time to spotlight one of the world’s fastest-growing and deadliest cancers: Over 900,000 people are d
Meet Ophiomics at Global Health Exhibition 2025
Ophiomics is heading to Riyadh! We will be attending and exhibiting at the Global Health Exhibition, taking place 27–30 October. You can find us at
Why Precision Matters: How Machine Learning Powers HepatoDetect’s Accuracy in HCC Detection
Precision in IVD Tools: How Machine Learning Elevates HepatoDetect for Early HCC Detection Early detection of hepatocellular carcinoma (HCC) in patien
HepatoDetect: Real-World Lab Implementation for Seamless Clinical Integration
The most innovative diagnostic test is of little value if it cannot be implemented efficiently in real-world clinical settings. Current HCC surveillan
HepatoDetect: A New Era in HCC Surveillance for Patients with Cirrhosis
For patients with cirrhosis, early detection of hepatocellular carcinoma (HCC) can mean the difference between curative treatment and late-stage disea
New Meta-Analysis Shows That Current Liver Transplant Criteria Wrongly Exclude Patients Who Could Benefit From the Procedure
We are pleased to announce that our team’s latest work, “Hepatocellular Carcinoma Transplant Criteria Show Poor Negative Predictive Value: A Sys
Cost-effectiveness Analysis of Selection Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma
Congratulations Hugo Pereira on successfully completing his Master Programme on Mathematics Applied to Economics and Management 🎉 Hugo’s thes
If Precision Medicine Is the Future, Diagnostics Must Lead the Way: Insights from our CEO
Our CEO, José Pereira Leal, makes a compelling case for rebalancing how we fund and value healthcare innovation. In his latest piece, he argues that
New paper out – Esophageal Adenocarcinoma
👏💪 It’s out! Our latest study addresses a critical need in gastroenterology: early and accurate identification of Barrett’s Esophagus (BE) p
HepatoPredict – Available @ Ophiomics
We’re excited to announce that HepatoPredict, our CE-IVD prognostic tool to assess hepatocellular carcinoma (HCC) recurrence in the context of liver
HepatoDetect – Encouraging first results
HepatoDetect Shows Strong Potential for Early HCC Detection HepatoDetect, our AI-driven liquid biopsy platform designed for the early detection of hep
Transforming Liver Care through Genomics and AI
Now partnering with global institutions and investors to scale innovation where it matters most. Ophiomics is building the world’s first end-t
